Childhood immune thrombocytopenia: A changing therapeutic landscape

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 7, 2011, Pages 745-755

  Breakey, Vicky R ^a   Blanchette, Victor S ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

children; immune thrombocytopenia; Immune thrombocytopenic purpura

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; ELTROMBOPAG; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RHESUS D ANTIBODY; RITUXIMAB; ROMIPLOSTIM;

ACUTE DISEASE; ARTICLE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; AUTOIMMUNE THROMBOCYTOPENIA; CATARACT; CHILDHOOD DISEASE; CHILDHOOD IMMUNE THROMBOCYTOPENIA; CHRONIC DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; COMPUTER ASSISTED TOMOGRAPHY; COOMBS TEST; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; ECHOGRAPHY; EMERGENCY TREATMENT; FOLLOW UP; HEADACHE; HUMAN; HYPOTENSION; MULTIPLE CYCLE TREATMENT; NAUSEA; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPEATED DRUG DOSE; SERUM SICKNESS; SPLENECTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT RESPONSE; VOMITING;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; ISOANTIBODIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLATELET TRANSFUSION; PREDNISONE; PULSE THERAPY, DRUG; RH-HR BLOOD-GROUP SYSTEM; SPLENECTOMY; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 84255177131     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1297165     Document Type: Article

References (66)

1. Cines D B., Blanchette V S. Immune thrombocytopenic purpura. N Engl J Med 2002 346 13 995-1008
2. Nugent D, McMillan R, Nichol J L., Slichter S J. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br J Haematol 2009 146 6 585-596
3. George J N., Woolf S H., Raskob G E. et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996 88 1 3-40 (Pubitemid 26230668)
4. Provan D, Newland A, Norfolk D et al, British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003 120 4 574-596
5. Provan D, Stasi R, Newland A C. et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010 115 2 168-186
6. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther M. American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011 117 16 4190-4207
7. Blanchette V S., Carcao M. Childhood acute immune thrombocytopenic purpura: 20 years later. Semin Thromb Hemost 2003 29 6 605-617 (Pubitemid 38041412)
8. Blanchette V S., Price V. Childhood chronic immune thrombocytopenic purpura: unresolved issues. J Pediatr Hematol Oncol 2003 25 Suppl 1 S28-S33 (Pubitemid 37517915)
9. Blanchette V, Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management. Pediatr Clin North Am 2008 55 2 393-420 (Pubitemid 351442783)
10. Rodeghiero F, Stasi R, Gernsheimer T et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009 113 11 2386-2393
11. Stasi R, Amadori S, Osborn J, Newland A C., Provan D. Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia. PLoS Med 2006 3 3 e24
12. Dubansky A S., Boyett J M., Falletta J et al. Isolated thrombocytopenia in children with acute lymphoblastic leukemia: a rare event in a Pediatric Oncology Group Study. Pediatrics 1989 84 6 1068-1071 (Pubitemid 20003343)
13. Calpin C, Dick P, Poon A, Feldman W. Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? Arch Pediatr Adolesc Med 1998 152 4 345-347 (Pubitemid 28193293)
14. Kühne T, Buchanan G R., Zimmerman S et al, Intercontinental Childhood ITP Study Group Intercontinental Childhood ITP Study Group. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 2003 143 5 605-608 (Pubitemid 37452786)
15. Imbach P, Kühne T, Müller D et al. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer 2006 46 3 351-356 (Pubitemid 43201852)
16. Lilleyman J S., Paediatric Haematology Forum of the British Society for Haematology. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child 1994 71 3 251-253 (Pubitemid 24298274)
17. Kühne T, Imbach P, Bolton-Maggs PHB, Berchtold W, Blanchette V, Buchanan G R., Intercontinental Childhood ITP Study Group. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 2001 358 9299 2122-2125 (Pubitemid 34094903)
18. Woerner S J., Abildgaard C F., French B N. Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Pediatrics 1981 67 4 453-460 (Pubitemid 11061312)
19. Butros L J., Bussel J B. Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol 2003 25 8 660-664 (Pubitemid 36959433)
20. Neunert C E., Buchanan G R., Imbach P et al, Intercontinental Childhood ITP Study Group Registry II Participants. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 2008 112 10 4003-4008
21. Blanchette V, Imbach P, Andrew M et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994 344 8924 703-707 (Pubitemid 24281420)
22. Carcao M D., Zipursky A, Butchart S, Leaker M, Blanchette V S. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl 1998 424 71-74 (Pubitemid 28410866)
23. Tarantino M D., Young G, Bertolone S J. et al, Acute ITP Study Group. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. J Pediatr 2006 148 4 489-494
24. Buchanan G R., Holtkamp C A. Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial. Am J Pediatr Hematol Oncol 1984 6 4 355-361 (Pubitemid 15139664)
25. Blanchette V S., Luke B, Andrew M et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993 123 6 989-995 (Pubitemid 23353267)
26. Gaines A R. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood 2005 106 5 1532-1537 (Pubitemid 41208562)
27. Imbach P, Akatsuka J, Blanchette V et al. Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. Eur J Pediatr 1995 154 9, Suppl 4 S60-S64
28. Sobota A, Neufeld E J., Lapsia S, Bennett C M. Response to mercaptopurine for refractory autoimmune cytopenias in children. Pediatr Blood Cancer 2009 52 1 80-84
29. Hilgartner M W., Lanzkowsky P, Smith C H. The use of azathioprine in refractory idiopathic thrombocytopenic purpura in children. Acta Paediatr Scand 1970 59 4 409-415
30. Quiquandon I, Fenaux P, Caulier M T., Pagniez D, Huart J J., Bauters F. Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases. Br J Haematol 1990 74 2 223-228 (Pubitemid 20041099)
31. Andersen J C. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 1994 330 22 1560-1564 (Pubitemid 24160959)
32. Kühne T, Freedman J, Semple J W., Doyle J, Butchart S, Blanchette V S. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. J Pediatr 1997 130 1 17-24 (Pubitemid 27492714)
33. Cuker A, Cines D B. Immune thrombocytopenia. Hematology (Am Soc Hematol Educ Program) 2010 2010 377-384 http://asheducationbook.hematology.org
34. Arnold D M., Dentali F, Crowther M A. et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 2007 146 1 25-33 (Pubitemid 351650318)
35. Bennett C M., Rogers Z R., Kinnamon D D. et al, Pediatric Rituximab/ITP Study Group and the Glaser Pediatric Research Network. Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood 2006 107 7 2639-2642
36. Mueller B U., Bennett C M., Feldman H A. et al, Pediatric Rituximab/ITP Study Group Glaser Pediatric Research Network. One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab. Pediatr Blood Cancer 2009 52 2 259-262
37. Carson K R., Evens A M., Richey E A. et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009 113 20 4834-4840
38. Kaushansky K. Thrombopoietin. N Engl J Med 1998 339 746-754 (Pubitemid 28417359)
39. Kaushansky K. Historical review: megakaryopoiesis and thrombopoiesis. Blood 2008 111 3 981-986 (Pubitemid 351213374)
40. Bussel J B., Kuter D J., Pullarkat V, Lyons R M., Guo M, Nichol J L. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood 2009 113 10 2161-2171
41. Kuter D J., Rummel M, Boccia R et al. Romiplostim or standard of care in patients with immune thrombocytopenia. N Engl J Med 2010 363 20 1889-1899
42. Bussel J B., Cheng G, Saleh M N. et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007 357 22 2237-2247 (Pubitemid 350190754)
43. Price V E., Dutta S, Blanchette V S. et al. The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto. Pediatr Blood Cancer 2006 46 5 597-603
44. Crary S E., Buchanan G R. Vascular complications after splenectomy for hematologic disorders. Blood 2009 114 14 2861-2868
45. van Hoff J, Ritchey A K. Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura. J Pediatr 1988 113 3 563-566
46. Shatz D V., Schinsky M F., Pais L B., Romero-Steiner S, Kirton O C., Carlone G M. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy. J Trauma 1998 44 5 760-765, discussion 765766
47. Williams J A., Boxer L A. Combination therapy for refractory idiopathic thrombocytopenic purpura in adolescents. J Pediatr Hematol Oncol 2003 25 3 232-235 (Pubitemid 36292839)
48. Arnold D M., Nazi I, Santos A et al. Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura. Blood 2010 115 1 29-31
49. Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010 116 1 7-15
50. Teachey D T., Seif A E., Grupp S A. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Br J Haematol 2010 148 2 205-216
51. Oliveira J B., Bleesing J J., Dianzani U et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 2010 116 14 e35-e40
52. Rao V K., Dugan F, Dale J K. et al. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome. Br J Haematol 2005 129 4 534-538 (Pubitemid 40769903)
53. Teachey D T., Greiner R, Seif A et al. Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome. Br J Haematol 2009 145 1 101-106
54. Seif A E., Manno C S., Sheen C, Grupp S A., Teachey D T. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study. Blood 2010 115 11 2142-2145
55. Beck C E., Nathan P C., Parkin P C., Blanchette V S., Macarthur C. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr 2005 147 4 521-527 (Pubitemid 41446548)
56. Tamminga R, Berchtold W, Bruin M, Buchanan G R., Kühne T. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS). Br J Haematol 2009 146 2 180-184
57. Najean Y, Rain J D., Billotey C. The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. Br J Haematol 1997 97 3 547-550 (Pubitemid 27261616)
58. Cuker A, Cines D B. Evidence-based mini-review: Is indium-labeled autologous platelet scanning predictive of response to splenectomy in patients with chronic immune thrombocytopenia? Hematology (Am Soc Hematol Educ Program) 2010 2010 385-386 http://asheducationbook.hematology.org
59. Buchanan G R., Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 2002 141 5 683-688 (Pubitemid 35292768)
60. Klaassen R J., Blanchette V S., Barnard D et al. Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools. J Pediatr 2007 150 5 510-515, 515, e1
61. Mathias S D., Bussel J B., George J N., McMillan R, Okano G J., Nichol J L. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health Qual Life Outcomes 2007 5 11
62. Drachman J G. Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood 2004 103 2 390-398 (Pubitemid 38140065)
63. Blanchette V S., Kirby M A., Turner C. Role of intravenous immunoglobulin G in autoimmune hematologic disorders. Semin Hematol 1992 29 3, Suppl 2 72-82
64. Ben-Yehuda D, Gillis S, Eldor A, Israeli ITP Study Group. Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Acta Haematol 1994 91 1 1-6 (Pubitemid 24131992)
65. Mantadakis E, Buchanan G R. Elective splenectomy in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2000 22 2 148-153 (Pubitemid 32290151)
66. Kühne T, Blanchette V, Buchanan G R. et al, Intercontinental Childhood ITP Study Group. Splenectomy in children with idiopathic thrombocytopenic purpura: a prospective study of 134 children from the Intercontinental Childhood ITP Study Group. Pediatr Blood Cancer 2007 49 6 829-834 (Pubitemid 47519522)